Christopher Wilson. Advancing CRISPR Technologies for Therapeutic Application. Presented at the TIDES Oligonucleotide & Peptide Therapeutics conference, May 3, 2017.

Aug

28

Editas Medicine to Participate in Upcoming Investor Conferences

Aug

7

Editas Medicine Announces Second Quarter 2024 Results and Business Updates

Jul

31

Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update